PortfoliosLab logo
DHR vs. WST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DHR and WST is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.4

Performance

DHR vs. WST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Danaher Corporation (DHR) and West Pharmaceutical Services, Inc. (WST). The values are adjusted to include any dividend payments, if applicable.

0.00%100,000.00%200,000.00%300,000.00%400,000.00%NovemberDecember2025FebruaryMarchApril
286,857.79%
22,654.27%
DHR
WST

Key characteristics

Sharpe Ratio

DHR:

-0.77

WST:

-0.82

Sortino Ratio

DHR:

-0.96

WST:

-0.90

Omega Ratio

DHR:

0.87

WST:

0.83

Calmar Ratio

DHR:

-0.55

WST:

-0.76

Martin Ratio

DHR:

-1.37

WST:

-1.80

Ulcer Index

DHR:

15.85%

WST:

24.88%

Daily Std Dev

DHR:

28.41%

WST:

54.63%

Max Drawdown

DHR:

-65.30%

WST:

-59.29%

Current Drawdown

DHR:

-32.06%

WST:

-54.13%

Fundamentals

Market Cap

DHR:

$140.63B

WST:

$15.22B

EPS

DHR:

$5.16

WST:

$6.70

PE Ratio

DHR:

38.08

WST:

31.43

PEG Ratio

DHR:

1.90

WST:

3.66

PS Ratio

DHR:

5.90

WST:

5.26

PB Ratio

DHR:

2.76

WST:

5.88

Total Revenue (TTM)

DHR:

$23.82B

WST:

$2.90B

Gross Profit (TTM)

DHR:

$14.23B

WST:

$1.00B

EBITDA (TTM)

DHR:

$6.65B

WST:

$685.60M

Returns By Period

In the year-to-date period, DHR achieves a -13.99% return, which is significantly higher than WST's -34.46% return. Over the past 10 years, DHR has outperformed WST with an annualized return of 19.25%, while WST has yielded a comparatively lower 14.88% annualized return.


DHR

YTD

-13.99%

1M

-6.16%

6M

-19.45%

1Y

-19.42%

5Y*

6.58%

10Y*

19.25%

WST

YTD

-34.46%

1M

-4.61%

6M

-30.23%

1Y

-41.61%

5Y*

2.10%

10Y*

14.88%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DHR vs. WST — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DHR
The Risk-Adjusted Performance Rank of DHR is 1414
Overall Rank
The Sharpe Ratio Rank of DHR is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of DHR is 1414
Sortino Ratio Rank
The Omega Ratio Rank of DHR is 1313
Omega Ratio Rank
The Calmar Ratio Rank of DHR is 1717
Calmar Ratio Rank
The Martin Ratio Rank of DHR is 1313
Martin Ratio Rank

WST
The Risk-Adjusted Performance Rank of WST is 88
Overall Rank
The Sharpe Ratio Rank of WST is 99
Sharpe Ratio Rank
The Sortino Ratio Rank of WST is 1515
Sortino Ratio Rank
The Omega Ratio Rank of WST is 88
Omega Ratio Rank
The Calmar Ratio Rank of WST is 77
Calmar Ratio Rank
The Martin Ratio Rank of WST is 22
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DHR vs. WST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Danaher Corporation (DHR) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for DHR, currently valued at -0.77, compared to the broader market-2.00-1.000.001.002.003.00
DHR: -0.77
WST: -0.82
The chart of Sortino ratio for DHR, currently valued at -0.96, compared to the broader market-6.00-4.00-2.000.002.004.00
DHR: -0.96
WST: -0.90
The chart of Omega ratio for DHR, currently valued at 0.87, compared to the broader market0.501.001.502.00
DHR: 0.87
WST: 0.83
The chart of Calmar ratio for DHR, currently valued at -0.55, compared to the broader market0.001.002.003.004.005.00
DHR: -0.55
WST: -0.76
The chart of Martin ratio for DHR, currently valued at -1.37, compared to the broader market-5.000.005.0010.0015.0020.00
DHR: -1.37
WST: -1.80

The current DHR Sharpe Ratio is -0.77, which is comparable to the WST Sharpe Ratio of -0.82. The chart below compares the historical Sharpe Ratios of DHR and WST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00NovemberDecember2025FebruaryMarchApril
-0.77
-0.82
DHR
WST

Dividends

DHR vs. WST - Dividend Comparison

DHR's dividend yield for the trailing twelve months is around 0.57%, more than WST's 0.29% yield.


TTM20242023202220212020201920182017201620152014
DHR
Danaher Corporation
0.57%0.47%0.43%0.38%0.26%0.32%0.44%0.62%0.60%36.46%0.80%0.47%
WST
West Pharmaceutical Services, Inc.
0.29%0.25%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%0.77%

Drawdowns

DHR vs. WST - Drawdown Comparison

The maximum DHR drawdown since its inception was -65.30%, which is greater than WST's maximum drawdown of -59.29%. Use the drawdown chart below to compare losses from any high point for DHR and WST. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%NovemberDecember2025FebruaryMarchApril
-32.06%
-54.13%
DHR
WST

Volatility

DHR vs. WST - Volatility Comparison

Danaher Corporation (DHR) has a higher volatility of 17.28% compared to West Pharmaceutical Services, Inc. (WST) at 15.01%. This indicates that DHR's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%NovemberDecember2025FebruaryMarchApril
17.28%
15.01%
DHR
WST

Financials

DHR vs. WST - Financials Comparison

This section allows you to compare key financial metrics between Danaher Corporation and West Pharmaceutical Services, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items